Novel Coronavirus (SARS-CoV-2/COVID-19)
The number of uninsured U.S. residents did not change substantially during the first 12 months of the COVID-19 pandemic, according to a report released by the Department of Health and Human Services.
The authors of a recent study that looked at CARES Act Provider Relief Funds allocated to health care institutions made arbitrary choices about which payments to include in the analysis. This resulted in incomplete or skewed findings.
The AHA released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency
A documentary premiering in Washington, D.C., and opening in theaters Nov. 19 features doctors, nurses and patients at Long Island Jewish Medical Center in Queens, N.Y., as they navigate the early days of the COVID-19 crisis, Axios AM reports.
A Food and Drug Administration advisory committee voted to recommend an emergency use authorization of Pfizer鈥檚 COVID-19 vaccine for children age 5-11.
In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and鈥
A recent study published in JAMA Health Forum that examines CARES Act Provider Relief Funds allocated to health care providers misses the point of those payments and makes arbitrary choices about which payments to include, writes Ashley Thompson, AHA senior vice president for public policy analysis鈥
A recent study published in JAMA Health Forum (鈥淎ssociation Between COVID-19 Relief Funds and Hospital Characteristics in the U.S.鈥) that examines CARES Act Provider Relief Funds allocated to health care providers misses the point of those payments and makes arbitrary choices about which payments鈥
In a letter to Sens. AHA expresses support for the Student Assisted Vaccination Effort Act (S. 2114).
The National Institutes of Health will use $70 million from the American Rescue Plan Act for a program to speed development of accurate and reliable over-the-counter tests for COVID-19, the Department of Health and Human Services announced.